Download full report with analyst certification and important disclosures
Oct 15 2021, 08:05 IST/BST
AIB Group
Capital accretive NPE sale
DAVY VIEW
AIB’s capital accretive non-performing exposure (NPE) sale demonstrates ongoing progress against medium-term targets, moving NPEs below 6%. The sale also avoids future calendar provisioning losses if the portfolio was held. In this context, the sale price demonstrates a conservative provisioning approach and is in stark contrast to the value if it were held by AIB on its balance sheet in the coming years.
